Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
Status:
Active, not recruiting
Trial end date:
2021-05-15
Target enrollment:
Participant gender:
Summary
This pilot study is being performed to assess the efficacy and safety of inhaled ensifentrine
delivered via pMDI compared with a matching placebo in conjunction with standard of care
treatments on recovery in patients hospitalized due to COVID-19 infection.